Improving statin use in Black patients with heart disease
ACHIEVE
This study is working to help Black patients with heart disease take their cholesterol-lowering statin medications more regularly by having pharmacists team up with them and their doctors to overcome any challenges they face in sticking to their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10918278 on NIH RePORTER |
What this research studies
This research focuses on enhancing the use of statin medications among individuals with a history of atherosclerotic cardiovascular disease (ASCVD), particularly within the Black population. It involves a multi-center trial where pharmacists will collaborate with patients and their healthcare providers to address barriers to medication adherence and ensure appropriate statin therapy is initiated. By utilizing commercial payer records, eligible patients will be identified, and tailored interventions will be implemented to improve both prescription rates and adherence to statin therapy. The goal is to create a sustainable model that can be integrated into existing healthcare systems to benefit patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black individuals with a history of atherosclerotic cardiovascular disease who may not be receiving appropriate statin therapy.
Not a fit: Patients who do not identify as Black or those without a history of atherosclerotic cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the use of life-saving statin medications among Black patients with heart disease, ultimately reducing cardiovascular events and improving health outcomes.
How similar studies have performed: Previous research has shown that targeted interventions can improve medication adherence in specific populations, suggesting that this approach may be effective.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Granger, Christopher B. — Duke University
- Study coordinator: Granger, Christopher B.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.